Results 1 to 10 of about 13,758 (226)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]
Diagnostics, 2020 Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual ...
McKayla J. Riggs +3 more
doaj +3 more sources
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
Journal of Anaesthesiology Clinical Pharmacology, 2019 Patients with peritoneal carcinomatosis were considered incurable with dismal survival rates till hyperthermic intraperitoneal chemotherapy after optimal cytoreductive surgery evolved. Perioperative management for these procedures is complex and involves
Nishkarsh Gupta +5 more
doaj +3 more sources
Simulating drug penetration during hyperthermic intraperitoneal chemotherapy [PDF]
Drug Delivery, 2021 Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41 ...
Daan R. Löke +6 more
doaj +3 more sources
Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Annals of Hepatology, 2012 Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a consequence of this treatment modality.
Heriberto Medina-Franco +3 more
doaj +3 more sources
Hyperthermic intraperitoneal chemotherapy: Ideal and reality
Asian Journal of SurgeryHyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong +8 more
doaj +3 more sources
Hyperthermic Intraperitoneal Chemotherapy: A Critical Review [PDF]
Cancers, 2021 With increasing awareness amongst physicians and improved radiological imaging techniques, the peritoneal cavity is increasingly recognized as an important metastatic site in various malignancies. Prognosis of these patients is usually poor as traditional treatment including surgical resection or systemic treatment is relatively ineffective ...
Wim Ceelen +2 more
openaire +5 more sources
Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer [PDF]
Obstetrics & Gynecology Science, 2021 Objective To investigate the therapeutic efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) as consolidation treatment after completing first-line treatment in patients with advanced ovarian cancer.
Jieun Ko +8 more
doaj +1 more source
Current Situation of Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinoma
Zhongliu Fangzhi Yanjiu, 2021 Peritoneal carcinoma is a kind of malignant tumor which occurs and develops on the peritoneum, including primary and secondary tumors. Hyperthermic intraperitoneal chemotherapy is a combined therapy of intraperitoneal perfusion, hyperthermia and ...
ZHAN Hongjie, LIANG Han
doaj +1 more source
Current Oncology, 2023 Desmoplastic small round cell tumor is a very rare and highly aggressive soft tissue sarcoma, usually presenting with multiple intra-abdominal tumors in young males. Patients present with advanced disease and the overall survival is dismal.
Sophie J. M. Reijers +4 more
doaj +1 more source
Pleura and Peritoneum, 2022 Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais +4 more
doaj +1 more source